Skip to content

Clinical trials

Completed Hyperlipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Status: Completed Clear all

584 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20014
20025
200310
200431
200532
200627
200734
200817
200924
201022
201139
201229
201327
201424
201529
201632
201725
201825
201919
202017
202119
202222
202320
202415
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed584

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer21
AstraZeneca20
Amgen17
Takeda16
University Health Network, Toronto9
Chong Kun Dang Pharmaceutical8
Esperion Therapeutics, Inc.8
University of Toronto8
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.7
Boryung Pharmaceutical Co., Ltd6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias584
Hypertension134
Hypercholesterolemia99
Diabetes Mellitus86
Dyslipidemias69
Cardiovascular Diseases68
Obesity60
Diabetes Mellitus, Type 232
Metabolic Syndrome28
Insulin Resistance24

Trials

Showing 26 to 50 of 584. Each trial links to its page on Pharma Observatory.

484 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.